I wish you guys would get together on your bashing. You say that no CEO would avoid filing first with the FDA and the other bashers say that the FDA told them not to file.
It's hard to know which basher to trust these days.
I don’t get why posters can’t comprehend this and call it FUD. This is just pharma101. If the rebuttal is their current manufacturing structure being a limitation, well that is still a failure on behalf of NWBO.
However I don’t think the trial is a failure. A little messy sure but that is just a product of the knowledge at the time of trial design. The lack of filing is a failure on management, having everything outsourced, and not building a strong internal team IMO.
Market Data 
Markets 
AI
